As of 2026-10-04, the Fair Value of AnaptysBio Inc (ANAB) is -4.52 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 48.53 USD, the upside of AnaptysBio Inc is -109.32%.
With the market price of 48.53 USD and our fair value calculation, AnaptysBio Inc (ANAB) is not a good investment. Investing in AnaptysBio stocks now will result in a potential loss of 109.32%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -57.80 | -128.72 | -163.62 | -145.23 | -13.23 | -101.72 |
| YoY growth | -190.02% | -122.70% | -27.11% | 11.24% | 90.89% | -47.54% |
| Market Cap (mil) | 1,436.97 |
| P/E | |
| Forward P/E |
| EPS | -0.90 |
| Avg earnings growth rate | -47.54% |
| TTM earnings | -26.79 |